|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing balances with other financial institutions | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Total Cash and cash equivalents | ||||||||||||||||||||
| Investment securities: | ||||||||||||||||||||
| HTM, at amortized cost (fair value $346,306 and $321,702, respectively) | ||||||||||||||||||||
| AFS, at fair value (amortized cost $513,616 and $426,512, respectively) | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Loans held-for-sale, at fair value | ||||||||||||||||||||
| Loans, net of unearned income | ||||||||||||||||||||
| Less: ACL - Loans | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Finance lease right-of-use asset | ||||||||||||||||||||
| Cash surrender value of life insurance | ||||||||||||||||||||
| Restricted investment in bank stocks | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit and other intangibles, net | ||||||||||||||||||||
| Foreclosed assets held-for-sale | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES & SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing demand | ||||||||||||||||||||
| Money Market | ||||||||||||||||||||
| Interest-bearing transaction accounts | ||||||||||||||||||||
| Time | ||||||||||||||||||||
| Total Deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Subordinated debt and trust preferred securities | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders' Equity: | ||||||||||||||||||||
| Common stock, par value $1.00 per share; 40,000,000 shares authorized at June 30, 2026 and December 31, 2025; 25,923,997 issued at June 30, 2026 and 23,567,094 at December 31, 2025; 25,320,686 outstanding at June 30, 2026 and 23,047,203 at December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost; 603,311 shares at June 30, 2026 and 519,891 at December 31, 2025 | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Common stock, issued (in shares) | ||||||||||||||||||||
Loading...
